Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Redford

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Pharmacy|March 1, 1995
Cyclosporine dosing for RAT W Redford, R E Small
American Pharmacy|November 1, 1994
Is methotrexate interaction critical?R E Small, T W Redford
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 1995
Update on pharmacotherapy of systemic lupus erythematosusT W Redford, R E Small
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotidesT W Redford, A K Yi, C T Ward, et al.
The Journal of Rheumatology|November 11, 1999
Tumor necrosis factor microsatellite markers TNFa5b5 and TNFa6b5 influence adverse reactions to parenteral gold in CaucasiansT I Evans, R E Small, T W Redford, et al.
International Immunology|October 25, 2001
Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaBA K Yi, J G Yoon, S C Hong, et al.
The Journal of Rheumatology|May 20, 1999
HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritisJ M Meyer, T I Evans, R E Small, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Pharmacy|March 1, 1995
Cyclosporine dosing for RAT W Redford, R E Small
American Pharmacy|November 1, 1994
Is methotrexate interaction critical?R E Small, T W Redford
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 1995
Update on pharmacotherapy of systemic lupus erythematosusT W Redford, R E Small
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotidesT W Redford, A K Yi, C T Ward, et al.
The Journal of Rheumatology|November 11, 1999
Tumor necrosis factor microsatellite markers TNFa5b5 and TNFa6b5 influence adverse reactions to parenteral gold in CaucasiansT I Evans, R E Small, T W Redford, et al.
International Immunology|October 25, 2001
Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaBA K Yi, J G Yoon, S C Hong, et al.
The Journal of Rheumatology|May 20, 1999
HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritisJ M Meyer, T I Evans, R E Small, et al.
Pageof 1